Sanctuary Advisors LLC Sells 9,879 Shares of Cardinal Health, Inc. (NYSE:CAH)

Sanctuary Advisors LLC lowered its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 16.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 48,709 shares of the company’s stock after selling 9,879 shares during the period. Sanctuary Advisors LLC’s holdings in Cardinal Health were worth $6,247,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Catalyst Capital Advisors LLC raised its holdings in Cardinal Health by 426.1% in the fourth quarter. Catalyst Capital Advisors LLC now owns 726 shares of the company’s stock worth $86,000 after purchasing an additional 588 shares during the period. Principal Financial Group Inc. raised its stake in Cardinal Health by 2.0% during the 4th quarter. Principal Financial Group Inc. now owns 299,861 shares of the company’s stock worth $35,465,000 after buying an additional 5,939 shares during the period. Strategic Financial Concepts LLC bought a new position in Cardinal Health during the fourth quarter worth about $93,000. Allworth Financial LP grew its stake in Cardinal Health by 34.8% in the fourth quarter. Allworth Financial LP now owns 3,771 shares of the company’s stock valued at $486,000 after acquiring an additional 973 shares during the period. Finally, Everhart Financial Group Inc. bought a new stake in shares of Cardinal Health in the fourth quarter worth about $218,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Up 0.3 %

NYSE CAH opened at $126.63 on Thursday. The company has a market capitalization of $30.59 billion, a P/E ratio of 23.63, a P/E/G ratio of 1.48 and a beta of 0.63. The firm has a 50-day moving average price of $123.25 and a two-hundred day moving average price of $116.81. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $132.84.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.60%. Cardinal Health’s dividend payout ratio is 37.69%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CAH. UBS Group lifted their price objective on Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a report on Monday, November 4th. Mizuho initiated coverage on Cardinal Health in a report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price objective for the company. Citigroup lifted their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. JPMorgan Chase & Co. upped their price objective on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Finally, Barclays upped their target price on shares of Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a report on Monday, November 4th. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus target price of $136.87.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.